Clinical Trial Update: Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating reduced-intensity transplant for medically refractory systemic lupus erythematosus and systemic sclerosis was terminated; results have …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus
• Systemic Sclerosis

Snippet

Sponsor: New York Medical College | Conditions: Systemic Lupus Erythematosus, Systemic Sclerosis | Phase 1 | Status: TERMINATED | Results posted: 2009-12-02